Source Natural

Why is Source Natural Foods & Herbal Supplements Ltd falling/rising?

As of 28-Jun, the stock price of Source Natural Foods & Herbal Supplements Ltd is currently at 108.00, reflecting a decline of 1.5% after a trend reversal. The stock has experienced significant year-to-date and annual declines, indicating a lack of investor confidence and a bearish trend.

As of 28-Jun, the stock price of Source Natural Foods & Herbal Supplements Ltd is falling, currently at 108.00, which reflects a decrease of 1.65 or 1.5%. This decline follows a trend reversal after two consecutive days of gains. Although the stock opened with a gain of 3.97% today and reached an intraday high of Rs 114, it ultimately underperformed the sector by 1.22%. <BR><BR>Additionally, the stock has shown a significant year-to-date decline of 19.97%, compared to a 9.53% drop in the benchmark Sensex. Over the past year, the stock has decreased by 32.12%, while the Sensex has only fallen by 6.83%. The recent performance indicates a lack of investor confidence, as evidenced by a 57.47% drop in delivery volume compared to the 5-day average. Furthermore, while the stock is trading above its 20-day moving averages, it remains below the 5-day, 50-day, 100-day, and 200-day moving averages, suggesting a bearish trend. Overall, these factors contribute to the stock's current decline.

Which are the latest news on Source Natural?

How big is Source Natural?

As of 10th June, Source Natural Foods & Herbal Supplements Ltd has a market capitalization of 70.00 Cr, with recent net sales of 70.38 Cr and a net profit of 3.39 Cr over the last four quarters.

As of 10th June, <BR><BR>Market Cap: Source Natural Foods & Herbal Supplements Ltd has a market capitalization of 70.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest four quarters is 70.38 Cr, while the sum of Net Profit for the same period is 3.39 Cr.<BR><BR>Balance Sheet Snapshot: The latest annual reporting period is March 2025, with Shareholder's Funds amounting to 22.36 Cr and Total Assets of 35.83 Cr.

Who are in the management team of Source Natural?

The management team of Source Natural includes Narayanan Narasimhan (Chairman), Arvind Varchaswi N (Managing Director), Tejagna Kashmira Katpitia (Executive Director), and several Independent Directors: Gowra Srinivas, Chandrakant Laxminarayan Rathi, Sriram Chandrasekaran, and Bharathy. This diverse team brings a wide range of expertise to the company.

The management team of Source Natural includes the following individuals:<BR><BR>1. **Narayanan Narasimhan** - Chairman & Non-Executive Director<BR>2. **Arvind Varchaswi N** - Managing Director<BR>3. **Tejagna Kashmira Katpitia** - Executive Director & Wholetime Director<BR>4. **Gowra Srinivas** - Independent Director<BR>5. **Chandrakant Laxminarayan Rathi** - Independent Director<BR>6. **Sriram Chandrasekaran** - Independent Director<BR>7. **Bharathy** - Independent Director<BR><BR>This team brings a diverse range of expertise to the company.

Who are the peers of the Source Natural?

Source Natural's peers include Bharat Immunolog, Phaarmasia, Bacil Pharma, and others. It has a below-average growth rating and the lowest 1-year return at -42.15% among its peers.

Peers: Bharat Immunolog, Phaarmasia, Bacil Pharma, Vineet Laborator, Samrat Pharma, Sunil Healthcare, Ajooni Biotech, Zenith Drugs, Vilin Bio Med.<BR><BR>Quality Snapshot: Excellent management risk is observed at Samrat Pharma and Ajooni Biotech, while Average management risk is found at Phaarmasia and JFL Life, and Below Average management risk is noted at Bharat Immunolog, Bacil Pharma, Vineet Laborator, Sunil Healthcare, Zenith Drugs, Vilin Bio Med, and the rest. Growth ratings show Excellent at JFL Life, Average at Phaarmasia and Ajooni Biotech, and Below Average at Bharat Immunolog, Bacil Pharma, Source Natural, Vineet Laborator, Samrat Pharma, Sunil Healthcare, Zenith Drugs, Vilin Bio Med, and the rest. Capital Structure is Excellent at Samrat Pharma, Good at Source Natural and Ajooni Biotech, and Below Average at Bharat Immunolog, Phaarmasia, Bacil Pharma, Vineet Laborator, Sunil Healthcare, Zenith Drugs, Vilin Bio Med, and the rest.<BR><BR>Return Snapshot: Phaarmasia has the highest 1-year return at 227.71%, while Source Natural has the lowest at -42.15%. Compared to its peers, Source Natural's 1-year return is significantly lower. Additionally, the six-month returns for Bharat Immunolog, Samrat Pharma, Sunil Healthcare, and Source Natural are negative.

What does Source Natural do?

Source Natural Foods & Herbal Supplements Ltd specializes in pharmaceuticals and biotechnology, focusing on allopathic and ayurvedic formulations. As of March 2026, it reported net sales of 21 Cr and a net profit of 1 Cr, with a market cap of INR 70 Cr.

Overview:<BR>Source Natural Foods & Herbal Supplements Ltd operates in the pharmaceuticals and biotechnology industry, focusing on allopathic and ayurvedic formulations.<BR><BR>History:<BR>The company was initially incorporated as Inwinex Pharmaceuticals Limited in 1995 and changed its name to Source Natural Foods & Herbal Supplements Ltd in 2011-12. The latest quarterly results reported net sales and profit for March 2026.<BR><BR>Financial Snapshot:<BR>Net Sales: 21 Cr (Quarterly Results - Mar 2026) <BR>Net Profit: 1 Cr (Quarterly Results - Mar 2026) <BR>Market-cap: INR 70 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 20.00 <BR>Industry P/E: 34 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.22 <BR>Return on Equity: 13.16% <BR>Price to Book: 2.65 <BR><BR>Contact Details:<BR>Address: 201 2nd Floor Sumeru Towers, 54/46 39 Jayanagar 4th Block Bangaluru Karnataka : 560041 <BR>Tel: 91-80-26087733 <BR>Email: info@source-natural.com <BR>Website: http://www.source-natural.com

Should I buy, sell or hold Source Natural Foods & Herbal Supplements Ltd?

Are Source Natural Foods & Herbal Supplements Ltd latest results good or bad?

Source Natural Foods & Herbal Supplements Ltd's latest results show strong revenue growth with net sales up 30.86% year-on-year, but profitability is a concern due to low profit margins and high tax rates. While sales performance is positive, ongoing operational challenges suggest caution for investors.

Source Natural Foods & Herbal Supplements Ltd's latest results present a mixed picture. On one hand, the company reported impressive revenue growth, with net sales reaching ₹21.03 crores, marking a 30.86% increase year-on-year and a 3.60% rise quarter-on-quarter. This is the highest quarterly revenue in the company's recent history, indicating strong market traction.<BR><BR>However, despite this top-line growth, profitability remains a concern. The net profit for Q4 FY26 was ₹1.24 crores, which, while showing a significant 51.22% increase from the previous quarter and a 96.83% rise year-on-year, translates to a modest profit margin of just 5.90%. This is notably lower than the margins achieved in previous periods, reflecting ongoing challenges with cost management and pricing pressures.<BR><BR>Additionally, the company's operating margin, although improved to 10.65% from the previous quarter's 7.54%, is still below historical averages. The elevated tax rate of 38.31% in Q4 FY26 has further eroded profitability, raising concerns about the sustainability of earnings.<BR><BR>Overall, while the revenue growth is a positive sign, the persistent margin compression and high tax burden suggest that the company is facing significant operational challenges. Therefore, the results can be seen as good in terms of sales growth but bad regarding profitability and operational efficiency. Investors should be cautious and monitor how the company addresses these issues moving forward.

When is the next results date for Source Natural Foods & Herbal Supplements Ltd?

The next results date for Source Natural Foods & Herbal Supplements Ltd is 28 May 2026.

The next results date for Source Natural Foods & Herbal Supplements Ltd is scheduled for 28 May 2026.

How has been the historical performance of Source Natural?

Source Natural has demonstrated significant growth in net sales and profitability, with net sales increasing from 19.77 Cr in Mar'23 to 44.92 Cr in Mar'25, and profit after tax rising from 2.12 Cr to 2.90 Cr during the same period. The company's total assets also grew from 21.45 Cr to 35.83 Cr, indicating a positive trend in financial performance.

Answer:<BR>The historical performance of Source Natural shows a significant upward trend in net sales and profitability over the years.<BR><BR>Breakdown:<BR>Source Natural's net sales have increased from 19.77 Cr in Mar'23 to 44.92 Cr in Mar'25, demonstrating robust growth. The total operating income followed a similar trajectory, rising from 19.77 Cr in Mar'23 to 44.92 Cr in Mar'25. Operating profit, excluding other income, also saw an increase, reaching 5.15 Cr in Mar'25 from 3.56 Cr in Mar'23. Profit before tax improved from 2.74 Cr in Mar'23 to 3.58 Cr in Mar'25, while profit after tax rose from 2.12 Cr to 2.90 Cr in the same period. The company's earnings per share (EPS) increased from 3.29 in Mar'23 to 4.5 in Mar'25, reflecting enhanced shareholder value. On the balance sheet, total assets grew from 21.45 Cr in Mar'23 to 35.83 Cr in Mar'25, alongside total liabilities which increased from 21.45 Cr to 35.83 Cr. The cash flow from operating activities remained stable, with a net cash inflow of 0.00 Cr in Mar'25, while cash and cash equivalents at the end of the period were 7.00 Cr, consistent with the previous year. Overall, Source Natural has shown a positive trend in sales, profitability, and asset growth over the past few years.

Is Source Natural overvalued or undervalued?

As of November 13, 2025, Source Natural is fairly valued with a PE ratio of 29.30 and a PEG ratio of 0.46, indicating reasonable valuation compared to peers, despite a 41.67% decline in stock performance over the past year.

As of 13 November 2025, the valuation grade for Source Natural has moved from attractive to fair, indicating a reassessment of its market position. The company is currently fairly valued based on its financial metrics, with a PE ratio of 29.30, an EV to EBITDA of 16.59, and a PEG ratio of 0.46. These ratios suggest that while the company has growth potential, its current valuation aligns with its earnings and growth prospects.<BR><BR>In comparison to its peers, Source Natural's valuation appears reasonable. For instance, Sun Pharma has a significantly higher PE ratio of 36.15, while Cipla, considered attractive, has a PE of 22.65. The notable outperformance of Source Natural's PEG ratio at 0.46 compared to peers like Divi's Lab, which has a PEG of 1.99, further supports the conclusion that Source Natural is fairly valued. Additionally, the company's stock has underperformed against the Sensex over the past year, with a decline of 41.67% compared to the Sensex's gain of 8.74%, reinforcing the notion that the stock may not be undervalued at this time.

What is the technical trend for Source Natural?

As of June 2, 2025, Source Natural's technical trend is neutral with mixed signals, showing mildly bullish indicators on weekly MACD and Bollinger Bands, but mildly bearish on monthly MACD and daily moving averages.

As of 2 June 2025, the technical trend for Source Natural has changed from mildly bullish to sideways. The weekly MACD indicates a mildly bullish stance, while the monthly MACD is mildly bearish, suggesting mixed signals across time frames. The Bollinger Bands are mildly bullish on both weekly and monthly charts, supporting a potential upward movement. However, daily moving averages are mildly bearish, indicating short-term weakness. The KST remains bullish on both weekly and monthly, and Dow Theory shows a mildly bullish trend weekly but mildly bearish monthly. Overall, the current technical stance is neutral with moderate strength, driven by conflicting signals from various indicators.

Who are the top shareholders of the Source Natural?

The top shareholder of Source Natural is Sriveda Sattva Private Limited, owning 74.37% of the shares, followed by public shareholder Guttikonda Vara Lakshmi with 2.96%. Individual investors hold 19.98%, with no mutual funds or foreign institutional investors involved.

The top shareholders of Source Natural include Sriveda Sattva Private Limited, which holds a significant 74.37% of the shares, making it the largest promoter. The highest public shareholder is Guttikonda Vara Lakshmi, who owns 2.96% of the shares. Additionally, individual investors collectively hold 19.98% of the company's shares. There are currently no mutual funds or foreign institutional investors holding shares in the company.

Has Source Natural declared dividend?

No Dividend History Available